Rheumatoid arthritis

Higher skin autofluorescence in individuals at risk for rheumatoid arthritis: results from a large population based cohort

Clin Exp RheumatolPublished Cross-sectional study

Authors' conclusion

Our results indicate that ACPA-positive individuals with RA risk have elevated SAF levels, which is regarded as a non-invasive marker for oxidative stress and a possible indicator for development of cardiovascular disease.

Study context

Population
Participants of the Dutch Lifelines Cohort Study with baseline skin autofluorescence (SAF) and anticitrullinated protein antibodies (ACPA) levels available
Participants
17,346 participants
Exposure
ACPA-positive groups and defined rheumatoid arthritis (RA) vs ACPA-negative controls
  • ACPA-negative controlsn = 17,211reference
  • ACPA-positive without joint complaintsn = 49
  • ACPA-positive RA riskn = 31
  • Defined RAn = 52
Outcome
Skin autofluorescence (SAF) levels
Follow-up
Baseline
Methodological detailspopulation-based cohort, multinomial regression
  • Population-based cohort
  • Multinomial regression

Main finding

As reported in the abstract

SAF levels vs controls

Odds ratio

2.04

P = 0.034

ACPA-positive RA risk

Odds ratio

3.10

P < 0.001

Defined RA

Odds ratio

1.07

P = 0.875

ACPA-positive without joint complaints

Observational data: associations, not effects.

Further findings

OutcomeORP value
SAF levels, age-adjustedDefined RA vs ACPA-negative controls2.09P = 0.011
SAF levels, age-adjustedACPA-positive RA risk vs ACPA-negative controls · effect comparable2.09

SAF levels, age-adjusted

Difference in defined RA remained significant after adjusting for smoking status, renal function or HbA1c

Original publication

Higher skin autofluorescence in individuals at risk for rheumatoid arthritis: results from a large population based cohort. Clin Exp Rheumatol. Published 25 November 2022. doi:10.55563/clinexprheumatol/6aan1g

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.